Figure 7. Genetic mutation status and the HR group predicted a higher risk of immune evasion in PCa patients. (A, B) The 20 most frequently mutated genes in the HR and LR groups in the TCGA cohort. (C, D) The discrepancies in 16 infiltrating immune cells and 29 immune functions of PCa patients in the two risk groups in the TCGA cohort. (E) The different risks of immune exclusion of PCa patients between the HR and LR groups in the TCGA cohort. (F–H) The expression differences in the immune checkpoints CD274 (F), PDCD1 (G) and CTLA-4 (H) for the two risk groups in the TCGA cohort.